Mass balance study LPM3770164 Huntington disease

ClinicalTrials.gov posted a new trial registration for NCT07516899, a mass balance study investigating LPM3770164 in Huntington disease participants. Mass balance studies are Phase 1 pharmacokinetic investigations that measure the quantitative disposition of a drug candidate through comprehensive urine, feces, and blood sampling to account for total administered radioactivity or parent compound.

Trial sponsors and clinical investigators conducting Phase 1 or neurology studies should note this registration for potential collaboration opportunities, competitive intelligence, or patient referral pathways. The study listing provides structured protocol data including primary and secondary endpoints, study design parameters, and participating site information.